Eating Disorders Clinical and Research Program, Massachusetts General Hospital, Boston, Massachusetts.
Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
Int J Eat Disord. 2019 Apr;52(4):327-330. doi: 10.1002/eat.23052. Epub 2019 Feb 22.
We are very pleased to introduce a special issue of the International Journal of Eating Disorders on child and adolescent feeding and eating disorders and avoidant/restrictive food intake disorder (ARFID).
Contributions focused on five main themes: (1) the definition and assessment of ARFID; (2) the clinical phenomenology of ARFID; (3) similarities and differences between ARFID and anorexia nervosa (AN); (4) novel treatments for ARFID; and (5) new ideas for improving treatment outcomes in AN.
These papers highlight the importance of clear operationalization and measurement of the ARFID diagnostic criteria. ARFID phenotypes bear both similarities and important differences in clinical profile, course, and outcome from AN. Findings suggest the utility of adapting existing treatments for restrictive eating disorders to apply to ARFID and engender clinical creativity to move beyond existing treatments and develop novel interventions that address the heterogeneity of ARFID. Furthermore, burgeoning understanding of ARFID offers the potential that novel treatments for ARFID may also be applied to improve outcomes for AN.
This collection of papers features child and adolescent feeding and eating disorder patient groups that have been understudied and we hope that this catalyzes clinical research in these important presentations.
我们非常高兴地介绍《国际进食障碍杂志》的一个特刊，内容涉及儿童和青少年喂养及进食障碍和回避/限制型食物摄入障碍（ARFID）。
这些论文的贡献主要集中在五个主题上：（1）ARFID 的定义和评估；（2）ARFID 的临床现象学；（3）ARFID 与神经性厌食症（AN）的异同；（4）ARFID 的新治疗方法；（5）改善 AN 治疗效果的新思路。
这些论文强调了明确操作和测量 ARFID 诊断标准的重要性。ARFID 表型在临床特征、病程和与 AN 的结果方面既有相似之处，也有重要差异。研究结果表明，将现有的限制型进食障碍治疗方法应用于 ARFID 是有效的，并激发了临床创造力，超越了现有治疗方法，开发出针对 ARFID 异质性的新干预措施。此外，对 ARFID 的认识不断深入，为将 ARFID 的新治疗方法应用于改善 AN 的治疗结果提供了可能。
本论文集收录了一些在儿童和青少年进食障碍患者群体中研究不足的论文，我们希望这能促进对这些重要表现形式的临床研究。
